Nuclear translocation of phosphorylated YB-1 via small extracellular vesicles contributes to the malignant phenotype of triple negative breast cancer
This study by co-senior authors Lorico and Sossey-Alaoui demonstrates that small extracellular vesicles (sEVs) derived from triple-negative breast cancer cells deliver phosphorylated YB-1 to the nuclei of recipient cells via the VOR complex, thereby driving malignant stemness and metastasis, a process that can be therapeutically inhibited by blocking nuclear translocation with PRR851.